The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBabcock Regulatory News (BAB)

Share Price Information for Babcock (BAB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 510.00
Bid: 509.00
Ask: 510.00
Change: 0.00 (0.00%)
Spread: 1.00 (0.196%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 510.00
BAB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sale of Frazer-Nash and half year trading update

21 Oct 2021 07:00

RNS Number : 7479P
Babcock International Group PLC
21 October 2021
 

Completion of the sale of Frazer-Nash and half year trading update

 

21 October 2021

 

Babcock International Group PLC ("Babcock" or "the Group") announces the completion of the sale of Frazer-Nash and provides a short trading update for the half year ending 30 September 2021 (HY22).

 

Completion of the sale of Frazer-Nash

On 20 October 2021, Babcock completed the sale of Frazer-Nash Consultancy to KBR for a cash consideration of £293 million before adjustments and transaction costs. This sale forms part of our portfolio realignment, which aims to generate at least £400 million of proceeds, the majority of which will be used to reduce the Group's net debt. The Consultancy was part of Babcock's Marine sector and had revenue of £101 million in FY21 (FY20: £102 million), with profit before interest and tax of £14 million (FY20: £17 million).

 

Trading update for HY22

Trading for the Group in the first half of the year was in line with our expectations and our full year outlook remains unchanged.

 

The headline financial performance for the half year ended 30 September 2021, based on our draft management accounts, shows revenue of £2,228 million with underlying operating profit of £115 million.

 

Based on our draft management accounts, the Group's net debt at 30 September 2021 was £1,347 million (31 March 2021: £1,354 million), and £938 million excluding operating leases (31 March 2021: £772 million). The Group's net debt to EBITDA ratio (covenant basis) at 30 September 2021 was 2.8 times (31 March 2021: 2.5x).

 

 

For further information:

Simon McGough, Director of Investor Relations

+44 (0)7850 978 741

Kate Hill, Group Director of Communications

+44 (0)20 7355 5312

Tulchan Communications

Olivia Peters / Harry Cameron

+44 (0)20 7353 4200  

 

 

Note

The financial comparator figures for the half year ended 30 September 2020 (HY21) will be restated to include the results of our Contract Profitability and Balance Sheet review outlined alongside our FY21 results on 30 July 2021. These restatements will be made available ahead of the publication of our half year results on 7 December 2021.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCKZMZGZGRGMZZ
Date   Source Headline
26th Apr 20241:15 pmRNSHolding(s) in Company
1st Mar 20247:00 amRNSContract awarded to refit UK nuclear submarine
21st Feb 20245:58 pmRNSDirector/PDMR Shareholding
15th Feb 20247:05 amRNSDirector announcement
14th Feb 20245:36 pmRNSDirector/PDMR Shareholding
14th Feb 20249:00 amRNSDirector appointment
9th Feb 20244:26 pmRNSDirector/PDMR Shareholding
7th Feb 20247:00 amRNSCapital Markets Day
6th Feb 20244:58 pmRNSDirector/PDMR Shareholding
5th Feb 202411:29 amRNSDirector/PDMR Shareholding
5th Feb 20247:00 amRNSAmended Capital Markets Day start time
12th Jan 20247:00 amRNSNotice of Capital Markets Day
15th Dec 20234:51 pmRNSDirector/PDMR Shareholding
14th Nov 20237:00 amRNSResults for the six months ended 30 September 2023
10th Nov 202312:00 pmRNSBabcock signs £750 million infrastructure contract
7th Nov 20233:24 pmRNSHolding(s) in Company
30th Oct 20231:55 pmRNSHolding(s) in Company
28th Sep 20236:12 pmRNSResult of AGM
28th Sep 20237:00 amRNSAGM trading update
26th Sep 20235:57 pmRNSHolding(s) in Company
26th Sep 20235:56 pmRNSHolding(s) in Company
22nd Aug 20238:54 amRNSDirector/PDMR Shareholding
17th Aug 20232:52 pmRNSNotice of AGM
16th Aug 20235:16 pmRNSDirector/PDMR Shareholding
9th Aug 202310:00 amRNSDirector/PDMR Shareholding
4th Aug 20233:24 pmRNSDirector/PDMR Shareholding
3rd Aug 20233:34 pmRNSDirector/PDMR Shareholding
3rd Aug 202310:19 amRNSDirector/PDMR Shareholding
2nd Aug 20233:25 pmRNSDirector/PDMR Shareholding
2nd Aug 202310:22 amRNSDirector/PDMR Shareholding
31st Jul 20239:22 amRNSAnnual Financial Report
20th Jul 20237:16 amRNSFull year results for the year ended 31 March 2023
11th Jul 20237:00 amRNSDate of publication of FY23 preliminary statement
24th May 20238:54 amRNSDirectorate Change
20th Apr 20237:00 amRNSFY23 post close update and Type 31 contract update
1st Mar 20237:00 amRNSDisposal programme successfully concluded
15th Feb 20239:09 amRNSBabcock awarded contract to operate Skynet
2nd Feb 20238:13 amRNSDirectorate Change
20th Dec 202212:54 pmRNSStandard & Poor credit rating upgrade
9th Dec 20229:29 amRNSHolding(s) in Company
8th Dec 20229:06 amRNSHolding(s) in Company
22nd Nov 20227:00 amRNSHalf-year Report
9th Nov 20224:48 pmRNSHolding(s) in Company
3rd Nov 202212:13 pmRNSRestatement of pass-through revenue for HY22
3rd Nov 202211:08 amRNSRestatement of H1 2022 Results
21st Oct 20228:05 amRNSContract Win
18th Oct 20229:00 amRNSDirector appointment
13th Oct 202210:41 amRNSHolding(s) in Company
26th Sep 20224:00 pmRNSResult of AGM
26th Sep 20227:00 amRNSAGM Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.